✦ LIBER ✦

Efficacy and Safety of Besifloxacin Ophthalmic Suspension 0.6% Compared with Moxifloxacin Ophthalmic Solution 0.5% for Treating Bacterial Conjunctivitis

✍ Scribed by Marguerite B. McDonald; Eugene E. Protzko; Lynne S. Brunner; Timothy W. Morris; Wolfgang Haas; Michael R. Paterno; Timothy L. Comstock; Dale W. Usner

Book ID: 116805407
Publisher: Elsevier Science
Year: 2009
Tongue: English
Weight: 923 KB
Volume: 116
Category: Article
ISSN: 0161-6420
DOI: 10.1016/j.ophtha.2009.05.014

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Efficacy and Safety of Besifloxacin Opht

Efficacy and Safety of Besifloxacin Ophthalmic Suspension 0.6% in Pediatric Patients With Bacterial Conjunctivitis

✍ Timothy L. Comstock; Michael R. Paterno; Jennifer A. Lynch; Heleen H. DeCory; Da 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 48 KB

Safety and Tolerability of Besifloxacin

Safety and Tolerability of Besifloxacin Ophthalmic Suspension 0.6% in Patients With Bacterial Conjunctivitis

✍ Timothy L. Comstock; Michael R. Paterno; Jennifer A. Lynch; Heleen H. DeCory; Da 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 45 KB

Aqueous penetration of moxifloxacin 0.5%

Aqueous penetration of moxifloxacin 0.5% ophthalmic solution and besifloxacin 0.6% ophthalmic suspension in cataract surgery patients

✍ Junko Yoshida; Alisa Kim; Kimberly A. Pratzer; Walter J. Stark 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 181 KB

Safety and Tolerability of Besifloxacin

Safety and Tolerability of Besifloxacin Ophthalmic Suspension 0.6% in the Treatment of Bacterial Conjunctivitis

✍ Dr Timothy L. Comstock, Michael R. Paterno, Heleen H. DeCory, Dale W. Usner 📂 Article 📅 2010 🏛 Springer International Publishing AG 🌐 English ⚖ 154 KB

Phase III efficacy and safety study of b

Phase III efficacy and safety study of besifloxacin ophthalmic suspension 0.6% in the treatment of bacterial conjunctivitis

✍ Tepedino, Michael E.; Heller, Warren H.; Usner, Dale W.; Brunner, Lynne S.; Morr 📂 Article 📅 2009 🏛 Informa plc 🌐 English ⚖ 304 KB

Clinical Safety of Moxifloxacin Ophthalm

Clinical Safety of Moxifloxacin Ophthalmic Solution 0.5% (VIGAMOX®) in Pediatric and Nonpediatric Patients With Bacterial Conjunctivitis

✍ Lewis H. Silver; Adrienne M. Woodside; Dawnelle B. Montgomery 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 114 KB